What should you know about immune checkpoint inhibitor drugs?

The immune system uses checkpoint signals to prevent excessive activity. Some cancers use these signals to avoid immune attack. A checkpoint inhibitor blocks a selected interaction, which can help immune cells respond to the tumour. The medicine does not work for every cancer or every person, so the treatment choice depends on the cancer type, its extent, previous treatment, overall health, and relevant test results.

Because the treatment changes immune activity, inflammation can occur in healthy organs. Problems may involve the skin, bowel, lungs, liver, hormone glands, kidneys, or nervous system. They can appear during treatment or after a dose, and symptoms should be reported early.

Before treatment, give your oncology team a complete medicine list and mention autoimmune conditions, organ transplants, allergies, and previous immune treatments. Keep the team’s contact details available. Do not start a new medicine, supplement, or vaccination without checking first. Record new symptoms, their timing, and any change after treatment so the team can decide whether monitoring, testing, or treatment is needed.

Contact your oncology team promptly for new or worsening diarrhoea, abdominal pain, rash, severe tiredness, yellowing of the skin, dark urine, reduced urine, persistent cough, chest pain, or breathlessness. Seek urgent help for severe breathing difficulty, confusion, fainting, sudden weakness, or swelling of the face or throat. Do not wait for the next scheduled infusion if symptoms are significant.

Which checkpoint pathway does my medicine target? What is the intended treatment plan, and how will response be assessed? Which symptoms require a same-day call? Could my other medicines or medical conditions affect treatment? What happens if immune-related inflammation is suspected?